tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Corbus Pharmaceuticals price target lowered to $53 from $56 at Oppenheimer
PremiumThe FlyCorbus Pharmaceuticals price target lowered to $53 from $56 at Oppenheimer
2M ago
Corbus Pharmaceuticals Reports Q2 2025 Financials and Updates
Premium
Company Announcements
Corbus Pharmaceuticals Reports Q2 2025 Financials and Updates
2M ago
Corbus Pharmaceuticals: Promising Outlook with Key Data Releases and Strong Financial Position
Premium
Ratings
Corbus Pharmaceuticals: Promising Outlook with Key Data Releases and Strong Financial Position
2M ago
Corbus Pharmaceuticals initiates MAD portion of its Phase 1 trial for CRB-913
PremiumThe FlyCorbus Pharmaceuticals initiates MAD portion of its Phase 1 trial for CRB-913
3M ago
Corbus says first patient dosed in PD-1 combo arm of Phase 1 study of CRB-701
Premium
The Fly
Corbus says first patient dosed in PD-1 combo arm of Phase 1 study of CRB-701
3M ago
Corbus Pharmaceuticals: Strategic Positioning and Promising Pipeline Drive Buy Rating
Premium
Ratings
Corbus Pharmaceuticals: Strategic Positioning and Promising Pipeline Drive Buy Rating
4M ago
Corbus Pharmaceuticals price target lowered to $58 from $65 at RBC Capital
PremiumThe FlyCorbus Pharmaceuticals price target lowered to $58 from $65 at RBC Capital
5M ago
Corbus Pharmaceuticals price target lowered to $56 from $60 at Oppenheimer
Premium
The Fly
Corbus Pharmaceuticals price target lowered to $56 from $60 at Oppenheimer
5M ago
Corbus Pharmaceuticals price target lowered to $40 from $50 at H.C. Wainwright
Premium
The Fly
Corbus Pharmaceuticals price target lowered to $40 from $50 at H.C. Wainwright
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100